9780470434673

Drug Truths Dispelling the Myths About Pharma R & D

by
  • ISBN13:

    9780470434673

  • ISBN10:

    0470434678

  • Edition: 1st
  • Format: eBook
  • Copyright: 2008-12-22
  • Publisher: Wiley

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $30.88 Save up to $3.09
  • Rent Book $27.79
    Add to Cart Free Shipping

    TERM
    PRICE
    DUE

Supplemental Materials

What is included with this book?

  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
  • The Rental copy of this book is not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Summary

This book answers the questions about the process and costs of pharmaceutical R & D in a compelling narrative focused on the discovery and development of important new medicines. It gives an insider's account of the pharmaceutical industry drug discovery process, the very real costs of misperceptions about the industry, the high stakes--both economic and scientific--of developing drugs, the triumphs that come when new compounds reach the market and save lives, and the despair that follows when new compounds fail. In the book, John LaMattina, former president of Pfizer Global Research and Development, weaves themes critical to a vital drug discovery environment in the context. This is a story that Dr. LaMattina is uniquely qualified to tell.

Author Biography

John L. LaMattina, PhD, retired as president of Pfizer Global Research and Development in 2007 where he managed more than 13,000 scientists and support professionals in the United States, Europe, and Asia. Dr. LaMattina has received numerous awards including an Honorary Doctor of Science degree from the University of New Hampshire.

Table of Contents

Acknowledgments.

Introduction.

PART 1: A MATTER OF THE HEART.

Chapter 1: Cholesterol Drugs Are Unnecessary.

Chapter 2: Industry is More Interested in "Me-Too" Drugs Than in Innovation.

Chapter 3: It Takes Industry Too Long to Discover New Drugs.

PART 2: THE ROLE OF PHARMACEUTICAL R&D IN HEALTHCARE.

Chapter 4: Drugs Are Discovered by Academia.

Chapter 5: New Medicines Add Costs but Little Benefit.

Chapter 6: Big Pharma Has Failed and Should Learn From Biotech Success.

PART 3: THE PROFIT MOTIVE.

Chapter 7: The Industry Invents Diseases.

Chapter 8: New Drugs Are Less Safe Than Traditional Medicines.

Chapter 9: Industry Spends More on Advertising Than R&D.

Chapter 10: Industry Does Not Care About Diseases of the Developing World.

PART 4: THE FUTURE.

Chapter 11: Big Pharma’s Day Has Passed.

Chapter 12: Final Reflections.

References.

Index.

Rewards Program

Write a Review